Showing results (261-270 of 272) with videos related to

Sort By:
Pageof 28
Scientific Reports|April 17, 2021
Functional disability is related to serum chemerin levels in rheumatoid arthritisMaria Luisa Vazquez-Villegas, Jorge I Gamez-Nava, A Miriam Saldaña-Cruz, et al.
Cell Reports Methods|September 17, 2021
Uncovering biomarkers during therapeutic neuromodulation with PARRM: Period-based Artifact Reconstruction and Removal MethodEvan M Dastin-van Rijn, Nicole R Provenza, Jonathan S Calvert, et al.
Toxicology Letters|August 14, 2016
Tributyltin chloride induces renal dysfunction by inflammation and oxidative stress in female ratsJoão V S Coutinho, Leandro C Freitas-Lima, Frederico F C T Freitas, et al.
Inflammopharmacology|September 14, 2018
Serum P-glycoprotein level: a potential biomarker of DMARD failure in patients with rheumatoid arthritisE E Perez-Guerrero, L Gonzalez-Lopez, J F Muñoz-Valle, et al.
The Journal of Clinical Investigation|December 23, 2025
Mismatch repair deficiency drives malignant progression and alters the tumor immune microenvironment in glioblastoma modelsMontserrat Puigdelloses Vallcorba, Nishant Soni, Seung-Won Choi, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
NAPRT expression and epigenetic regulation in pediatric rhabdomyosarcoma as a potential biomarker for NAMPT inhibitionAngela Kim, Prateek Bhardwaj, Collin D Heer, et al.
Genetic Testing and Molecular Biomarkers|March 18, 2021
Genotypic Analyses of the Sclerostin rs851056 and Dickkopf rs1569198 Polymorphisms in Mexican-Mestizo Postmenopausal Osteoporosis: A Case-Control StudyMaria L Vazquez-Villegas, Norma A Rodriguez-Jimenez, Betsabe Contreras-Haro, et al.
Molecular Cancer Therapeutics|April 22, 2026
NAPRT expression and epigenetic regulation in pediatric rhabdomyosarcoma as a potential biomarker for NAMPT inhibitionAngela Kim, Prateek Bhardwaj, Shahyan Rehman, et al.
Pageof 28